GSK2636771
-
Catalog number2793-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
-
DescriptionGSK2636771 is a potent, PI3Kβ-selective inhibitor, sensitive to PTEN cell lines.
-
CAS Number1372540-25-4
-
Structure AvailableY
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₂F₃N₃O₃
-
Molecular Weight433.42
-
Cell Permeabley
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA potent PI3Kβ-selective inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID56949517
-
SMILESCC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C2C=C(C=C3C(=O)O)N4CCOCC4)C
-
InChiInChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)
-
InChi KeyXTKLTGBKIDQGQL-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK2636771
-
Alternative nameGSK2636771
-